 |
 |
Thanks On 10/24/2015 2:50 AM, Rayilyn Brown wrote: > Tony > Dr. Drucker is the MD who developed the drug. Request for drug > trials probably should go to someone at Georgetown U like Dr. > Fernando.Pagan who did the Phase 1 trial. Pagan is trying to get > Novartis to reduce drug price for trial participants. > > You have sent your beautiful letter to the PIEN site. > > I wrote Pagan a letter on Oct 18 because I couldn't find an email > address. His snail mail address is : > > Fernando Pagan, MD > Georgetown University Medical Center > Department of Neurology > Pasquerilla Healthcare Center > 3800 Reservoir Road, N.W. > Washington D.C. 20007 > > Dr. Druker's email is > [log in to unmask] > > he answered my email which I posted > > Novartis contacts are: > > [log in to unmask] and > Carrie Scott at [log in to unmask] > [log in to unmask] > > hope this helps > > -----Original Message----- From: AW Adler > Sent: Friday, October 23, 2015 9:24 AM > To: [log in to unmask] > Subject: Nilotinib for Parkinson's > > Dr. Drucker, > I am a caregiver for my wife of 55 years who was diagnosed with PD about > 18 years ago. Please do all you can to fast track the trials for > Nilotinib for Parkinson's. If there is anything the Parkinson's > community can do to help in this regard, please let us know. We can deal > with the cost issue when the approval for PD is at hand. > > Thank you and God's speed. > > Tony Adler > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn